CVS HEALTH CORPORATION (CVS)

Consumer Discretionary · Pharmacy Retail · Price $92.92
Updated: Aug 28, 2026
Moderate Multiple
P/E of 24.52x is within the 15–25x range Zyberno considers reasonable for this type of businesses.
P/E Ratio (TTM)
24.52x
Above average P/E - growth expectations priced in
Earnings Yield
4.08%
1 / P/E Ratio
EPS (TTM)
$3.79
Diluted Earnings Per Share
Stock Price
$92.92
Current Market Price
PEG Ratio
4.18
Premium valuation relative to growth
Earnings Growth
5.03%
Net Income Growth (Linear)

🧮 CVS P/E Ratio Calculation

P/E Ratio = Stock Price ÷ Earnings Per Share (TTM)
Stock Price $92.92
÷
Earnings Per Share (TTM) $3.79
= P/E Ratio 24.52x

What is the P/E Ratio?

The Price-to-Earnings (P/E) Ratio is one of the most widely used valuation metrics. It tells you how much investors are willing to pay for each dollar of a company's earnings. Zyberno calculates P/E using trailing twelve month (TTM) diluted earnings from official SEC filings.

P/E Ratio = Stock Price ÷ Earnings Per Share (TTM)
Using diluted EPS which accounts for stock options and convertible securities

How to Interpret the P/E Ratio

Low P/E (Under 15x)

May indicate undervaluation, or the market expects declining earnings. Common in mature, slow-growth industries.

Average P/E (15-20x)

Roughly in line with historical S&P 500 average. Suggests fairly valued with moderate growth expectations.

High P/E (20-35x)

Investors expect above-average earnings growth. Common for technology companies and market leaders.

Very High P/E (35x+)

Extreme growth expectations priced in. Significant valuation risk if growth slows.

PEG Ratio: P/E Adjusted for Growth

The PEG Ratio addresses a key limitation of P/E by factoring in earnings growth. A PEG of 1.0 suggests fair value; below 1.0 may indicate undervaluation, while above 2.0 suggests a premium price for growth.

PEG Ratio = P/E Ratio ÷ Earnings Growth Rate
CVS: 24.52x ÷ 5.03% = 4.18

P/E Ratio Limitations

The P/E ratio doesn't work for companies with negative earnings. It can be manipulated by one-time charges or gains, and it doesn't account for debt levels or growth rates. Use P/E alongside PEG ratio, EV/EBITDA, and Owner Earnings yield for a complete picture.

Comparing Valuation Metrics

EPS: $3.79 →

The denominator in the P/E calculation. Represents profit allocated to each outstanding share.

Price-to-Book: N/A

Compares stock price to book value. Useful for asset-heavy industries like banking and manufacturing.

EV/EBITDA: N/A

Accounts for debt and is useful for comparing companies with different capital structures.

Owner Earnings Yield →

Warren Buffett's preferred metric. Shows cash return to owners as a percentage of market cap.

📊 Full CVS Stock Report

Intrinsic value, margin of safety, DCF valuation, and 250+ metrics.

📈 CVS Earnings Per Share

Deep dive into EPS trends, quarterly history, and earnings growth analysis.

🏆 CVS ROIC

Measure capital efficiency — how well management deploys every dollar invested.

💎 CVS Intrinsic Value

Calculate what CVS is truly worth using DCF and Owner Earnings models.

💵 CVS Owner Earnings

Warren Buffett's preferred measure of true earning power and cash generation.

🛡️ CVS Margin of Safety

See if CVS is trading below its intrinsic value.

View Full CVS Report Find More Quality Stocks
📊 Valuation Trilogy
Three interconnected metrics built on Owner Earnings
💎
Intrinsic Value
DCF Fair Value
$25.78
🛡️
Margin of Safety
Valuation Gap
-100.0%
🎯
Expected Return
Projected Annual
-38.1%
Click any metric for full methodology and detailed analysis

Summary: CVS P/E Ratio

CVS HEALTH CORPORATION (CVS) trades at a P/E of 24.52x, which Zyberno classifies as a moderate multiple — within the 15–25x range Zyberno considers reasonable for businesses across industries. Earnings yield: 4.08%.

Based on 0 quarters of SEC filings, CVS's EPS is currently $3.79 on a trailing twelve-month basis. Zyberno cross-references the P/E ratio with business quality — a high multiple on a high-quality business (strong ROE, ROIC, and FCF) carries less risk than the same multiple on a weaker business. For complete financial analysis, view the full CVS stock report on Zyberno.

Frequently Asked Questions

What is CVS's current P/E Ratio?

CVS HEALTH CORPORATION's trailing twelve month (TTM) P/E Ratio is 24.52x. Investors are paying $24.52 for every $1 of annual earnings.

Is CVS's P/E Ratio high or low?

CVS HEALTH CORPORATION (CVS) trades at a P/E of 24.52x, which Zyberno classifies as a moderate multiple — within the 15–25x range Zyberno considers reasonable for businesses across industries. Earnings yield: 4.08%.

What is CVS's earnings yield?

CVS's earnings yield is 4.08%, which is the inverse of the P/E ratio (1 ÷ P/E). This represents the theoretical return if all earnings were distributed to shareholders.

How is P/E Ratio calculated?

P/E Ratio = Stock Price ÷ EPS. For CVS: $92.92 ÷ $3.79 = 24.52x.

What is CVS's PEG Ratio?

CVS's PEG Ratio is 4.18. Premium valuation relative to growth. PEG below 1.0 is often considered undervalued, while above 2.0 may indicate overvaluation relative to growth.

📊 Full CVS Stock Report

See CVS's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.

🏆 CVS ROIC

Compare to Return on Invested Capital — the most comprehensive measure of capital efficiency.

📈 CVS ROE

Compare to Return on Equity and understand the impact of leverage on returns.

🎯 CVS Earnings Surprise (SUE)

See whether CVS is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.

👤 CVS Owner Earnings

Warren Buffett's preferred measure of true economic earnings available to owners.

💰 CVS Net Income

See the bottom-line profit that drives return calculations.

📊 CVS EPS

Earnings per share — net income on a per-share basis.

View Full CVS Report Find More Quality Stocks
Scroll to Top